Publication Details
Issue: Vol 10, No (2025)
Abstract
Relevance: Bronchial asthma (BA) remains one of the leading causes of patient disability, especially in combination with metabolic disorders. Type 2 diabetes mellitus (T2DM) is often accompanied by inflammatory changes affecting the airways. Insufficient control of bronchial asthma in the presence of T2DM can increase the frequency of exacerbations and the need for high doses of inhaled glucocorticosteroids. Hyperglycemia is associated with deterioration of lung function parameters, which reduces the effectiveness of basic therapy for BA. Patients with BA and T2DM have a high risk of hypoxic conditions and progression of obstructive disorders. The study is aimed at identifying factors influencing BA control in patients with T2DM.